- Emergent Health ( OTCPK:EMGE ) executes binding LOI to acquire Fusion Specialty Pharmacy subject to financing and execution of certain definitive agreements.
- "With the addition of Fusion, we will obtain licensure in all 50 States which will allow PharmaZu the ability to fill prescriptions nationwide, greatly expanding the reach of PharmaZu's pet medicine business." said Adam Brooks, President of PharmaZu.
- Fusion generated $3.8M in 2021 revenues, an ~100% increase Y/Y.
- The acquisition is projected to close during Q3 of this year.
- EMGE stock +247.5% at $0.028 in early trading.
For further details see:
Emergent Health rallies on acquiring Fusion Specialty Pharmacy